Skip ARKK’s Moonshots: This Fund Owns the AI Software Winners for 0.45%

Photo of David Beren
By David Beren Published

Quick Read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Skip ARKK’s Moonshots: This Fund Owns the AI Software Winners for 0.45%

© Quality Stock Arts / Shutterstock.com

The ARK Innovation ETF (NYSEARCA:ARKK) remains one of the most recognizable thematic funds on the market, marketed as a bet on disruptive innovation across AI, genomics, fintech, and autonomous technology. Investors hold ARKK for concentrated exposure to unprofitable, high-growth names that a market-cap index would underweight, and Cathie Wood’s active management is a large part of the appeal. The fund manages $8.24 billion across 50 holdings and trades at a 54 PE. For readers who want AI exposure but not moonshot risk, the iShares Future AI & Tech ETF (NASDAQ:WTAI) offers a different route into the same theme at a lower cost.

What the Fund Actually Owns Today

The April 30, 2026, filing shows the concentration issue plainly. The top 10 positions include a 2.70% weight in OpenAI Group PBC Series C, 4.98% in CRISPR Therapeutics, 5.18% in Advanced Micro Devices, and 2.32% in Bullish.

Per the fund’s latest snapshot, Tesla accounts for 9.87%, Tempus AI 5.76%, and Robinhood 5.03%, with the top 10 holdings representing 49.85% of assets. Roughly half the fund rests on 10 high-beta, story-driven positions, and the AI weighting is diluted by biotech, crypto exchanges, and consumer platforms.

Where the Incumbent Falls Short

Two problems bear on returns. First, cost: the expense ratio near 0.75% is roughly 30 basis points higher than WTAI’s stated 0.45% ratio. On a $50,000 position, that gap is $150 per year, compounding against the holder. Second, structure and returns: the fund is up 5.56% year to date and 15.28% over one year, with a five-year return of negative 33.23% from a July 20, 2021, starting price of $121.61. Over the same five years, the Nasdaq-100 index delivered 97.74%. The concentrated pre-profit tilt has trailed the broader index over that window.

What the Alternative Does Differently

The alternative is a passive, index-tracking fund whose portfolio is anchored in established AI beneficiaries with earnings on the board. The stocks doing the heavy lifting inside that basket illustrate the difference clearly. Micron posted Q3 FY26 revenue of $41.46 billion, up 345.7% year over year, and non-GAAP EPS of $25.11, driven by HBM4 shipments to lead AI customers.

The stock is up 228.99% year-to-date. Alphabet reported Q1 FY26 revenue of $109.90 billion with Google Cloud growing 63% year over year to $20.03 billion and a backlog above $460 billion. The stock is up 108.2% over the past year. Amazon delivered AWS revenue of $37.59 billion, growing 28% year over year, its fastest pace in 15 quarters, with 2026 capex guided near $200 billion.

Palo Alto Networks grew Q3 FY26 revenue 31.1% to $3.00 billion with NGS ARR climbing 60% to $8.10 billion. CEO Nikesh Arora cited “accelerating organic bookings growth as customers turn to us to secure their AI deployments at scale.” Shares are up 82.98% year to date. The composite result: the alternative is up 43.38% year-to-date and 73.72% over one year.

That is well ahead of the incumbent’s YTD return and meaningfully ahead of QQQ’s 15.48% YTD gain. Investors curious about which names inside the AI complex are actually monetizing today may find some overlap with the picks in 7 Stocks Powering the AI Boom.

The Real Tradeoffs and Practical Considerations

The alternative comes with real tradeoffs. Its index-based construction means no exposure to private-market positions like the incumbent’s 2.70% OpenAI stake, which is the kind of pre-IPO access retail investors rarely obtain elsewhere. It also concentrates in mega-cap technology, which correlates more tightly to the Nasdaq-100, so it offers less diversification against a broad Nasdaq drawdown.

And with a one-week return of -11.99 %, it can move sharply with shifts in AI-sector sentiment. In a tax-advantaged account, switching is mechanical. In a taxable account, a position purchased near the $121.61 level of July 2021 would realize a loss at today’s $81.19 price, which could offset gains elsewhere. Positions bought closer to current levels carry smaller tax friction.

A partial swap, holding the incumbent for its private-market exposure while adding the alternative as the AI core, preserves optionality on both sides. The incumbent still serves a specific investor: one who wants active selection, private-company access, and thematic breadth beyond AI.

For a holder whose primary goal was AI exposure through profitable, scaled businesses, the alternative captures that objective at a lower fee with holdings currently producing the earnings the incumbent’s thesis anticipated. The correct action depends on why the position was opened in the first place.

Contact [email protected] for any questions or corrections.

Photo of David Beren
About the Author David Beren →

David Beren has been a Flywheel Publishing contributor since 2022. Writing for 24/7 Wall St. since 2023, David loves to write about topics of all shapes and sizes. As a technology expert, David focuses heavily on consumer electronics brands, automobiles, and general technology. He has previously written for LifeWire, formerly About.com. As a part-time freelance writer, David’s “day job” has been working on and leading social media for multiple Fortune 100 brands. David loves the flexibility of this field and its ability to reach customers exactly where they like to spend their time. Additionally, David previously published his own blog, TmoNews.com, which reached 3 million readers in its first year. In addition to freelance and social media work, David loves to spend time with his family and children and relive the glory days of video game consoles by playing any retro game console he can get his hands on.

Continue Reading

Top Gaining Stocks

META Vol: 40,760,422
KMX Vol: 2,288,021
WY Vol: 6,523,553
SBAC Vol: 1,443,801
NVDA Vol: 148,249,982

Top Losing Stocks

MRNA Vol: 9,176,778
CTRA Vol: 73,319,495
CRWD Vol: 9,269,567
DDOG Vol: 5,135,556
EPAM Vol: 1,164,561